(Leinwand, Leslie Anne - 2010) -- Professor of Distinction
Overview
description
Professor Leinwand is recognized for her life-changing research on the genetics and molecular physiology of cardiomyopathies, diseases that weaken the heart muscle. She holds a Marsico Endowed Chair of Excellence for her teaching and research activities associated with the study of genetic heart defects. She works on fundamental processes such as gene mapping, gene organization, and RNA transcription. For her significant contributions to Colorado’s bioscience industry, she received a Colorado BioScience Association Lifetime Achievement Award in 2009. She is director of the Colorado Initiative in Molecular Biotechnology and was interim director of the Linda Crnic Institute for Down Syndrome. Professor Leinwand has won a number of national awards for her research and teaching. She is a Howard Hughes Medical Institute professor, a fellow of the American Association for the Advancement of Science, and a recipient of a National Heart, Lung, and Blood Institute MERIT award. She also is a professor in the cardiology division at the University of Colorado Anschutz Medical Campus and is a co-founder of Myogen Inc., a highly successful CU spinoff company begun in 1999 to research and treat cardiovascular ailments with small molecule therapeutics. Professor Leinwand came to CU- Boulder in 1995.
